Isoxicam.
D000328:Adult; D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003094:Collagen; D004347:Drug Interactions; D004361:Drug Tolerance; D004487:Edema / Q000517:prevention & control; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D009135:Muscular Diseases / Q000188:drug therapy; D010003:Osteoarthritis / Q000188:drug therapy*; D010105:Oxygenases / Q000037:antagonists & inhibitors; D010894:Piroxicam / Q000031:analogs & derivatives*; D051381:Rats; D013843:Thiazines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D013843:Thiazines; D010894:Piroxicam; C013580:isoxicam; D003094:Collagen; D010105:Oxygenases